NTLA Financials
Intellia Therapeutics Inc - Financial statements & key metrics
Stock Price
$12.70
Market Cap
$1.19B
P/E Ratio
-2.4
EPS
$-4.25
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$57.88M
Gross Profit
-
Operating Income
-
Net Income
$-519.02M
EPS (Diluted)
$-5.25
Balance Sheet Highlights
Total Assets
$1.19B
Total Liabilities
$319.06M
Shareholders Equity
-
Cash & Equivalents
$189.18M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-348.88M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
-808.9%
ROE
-52.1%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is NTLA revenue?
NTLA's most recent quarterly revenue was $57.88M. Annual revenue can be calculated by summing the four most recent quarters.
Is NTLA profitable?
NTLA reported a loss of $519.02M in the most recent quarter.
What is NTLA market cap?
NTLA has a market capitalization of $1.19B, making it a small-cap stock.
Does NTLA have debt?
View NTLA's balance sheet for debt information.
What is NTLA cash flow?
Cash flow data is available in the full financial statements.